Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.vbshilpa.com | |
Market Cap | 2,055.47 Cr. | |
Enterprise Value(EV) | 2,829.63 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.74 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 205.44 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.16 | Calculated using Price: 237.95 |
Dividend Yield | 0.46 | Period Ending 2022-03 |
No. of Shares Subscribed | 8.68 Cr. | 86,801,898 Shares |
FaceValue | 1 | |
About Shilpa Medicare Ltd. | ||
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications. |
1 Day |
|
+0.06% |
1 Week |
|
+0.51% |
1 Month |
|
-8.73% |
3 Month |
|
-15.34% |
6 Month |
|
-18.86% |
1 Year |
|
-44.75% |
2 Year |
|
-56.30% |
5 Year |
|
-40.79% |
10 Year |
|
+159.20% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 20.98 | 15.40 | 17.66 | 12.85 | 9.93 | 9.59 | 12.23 | 10.41 | 3.67 | |
Return on Capital Employed (%) | 20.48 | 17.90 | 19.69 | 15.28 | 11.13 | 10.45 | 12.38 | 10.73 | 5.94 | |
Return on Assets (%) | 12.23 | 9.18 | 11.41 | 8.69 | 6.92 | 7.04 | 8.59 | 6.33 | 2.20 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 396 | 547 | 639 | 987 | 1,085 | 1,198 | 1,329 | 1,479 | 1,822 | 1,783 | |
Non Curr. Liab. | 105 | 154 | 67 | 251 | 153 | 167 | 257 | 561 | 453 | 345 | |
Curr. Liab. | 167 | 189 | 222 | 237 | 266 | 253 | 411 | 587 | 612 | 783 | |
Minority Int. | 10 | 14 | 2 | -3 | -5 | -8 | -8 | -11 | -11 | -9 | |
Equity & Liab. | 678 | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,902 | |
Non Curr. Assets | 444 | 577 | 577 | 742 | 827 | 1,065 | 1,365 | 1,730 | 1,988 | 2,134 | |
Curr. Assets | 234 | 328 | 354 | 730 | 672 | 545 | 624 | 862 | 887 | 768 | |
Misc. Exp. not W/O | 0 | 0 | |||||||||
Total Assets | 678 | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,902 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 571 | 614 | 716 | 779 | 789 | 733 | 908 | 901 | 1,146 | 1,050 | |
Other Income | 9 | 7 | 11 | 29 | 33 | 16 | 22 | 40 | 21 | 17 | |
Total Income | 581 | 621 | 728 | 809 | 821 | 749 | 930 | 941 | 1,166 | 1,068 | |
Total Expenditure | -455 | -487 | -556 | -618 | -638 | -579 | -693 | -729 | -948 | -948 | |
PBIDT | 125 | 133 | 171 | 191 | 184 | 170 | 237 | 212 | 218 | 120 | |
Interest | -4 | -4 | -4 | -3 | -3 | -4 | -5 | -22 | -41 | -59 | |
Depreciation | -23 | -21 | -23 | -31 | -37 | -42 | -44 | -54 | -80 | -96 | |
Taxation | -20 | -35 | -36 | -42 | -34 | -26 | -33 | -49 | -42 | 7 | |
Exceptional Items | -3 | 0 | -2 | -5 | 20 | 61 | 9 | ||||
PAT | 75 | 73 | 105 | 104 | 103 | 110 | 155 | 146 | 61 | -27 | |
Minority Interest | 1 | 1 | 4 | 3 | 2 | 3 | 2 | 2 | 0 | -2 | |
Share Associate | -4 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 76 | 74 | 108 | 108 | 105 | 112 | 156 | 148 | 61 | -32 | |
Adjusted EPS | 10 | 10 | 14 | 13 | 13 | 14 | 19 | 18 | 7 | -4 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 44 | 70 | 69 | 129 | 37 | 45 | 147 | 124 | 47 | 105 | |
Cash Fr. Inv. | -95 | -49 | -195 | -109 | -262 | -9 | -196 | -290 | -404 | -286 | |
Cash Fr. Finan. | 66 | -28 | 136 | -20 | 313 | -61 | 10 | 176 | 436 | 83 | |
Net Change | 15 | -7 | 10 | 0 | 88 | -25 | -39 | 10 | 79 | -98 | |
Cash & Cash Eqvt | 17 | 9 | 18 | 6 | 100 | 74 | 34 | 44 | 123 | 25 |
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of the Q4 Conference call |
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Further to our letter dated 25 May 2023 regarding approval of Audited Standalone and Consolidated Financial Results of the Company for the quarter & year ended 31 March 2023 please find enclosed newspaper advertisements published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 in Sudhimoola andBusiness Line. |
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A of the SEBI (listing Obligations and Disclosure Requirements) Regulations 2015 read with CIR/CFD/CMD1/27/2019 dated February 8 2019 please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year 2022-23 issued by Mr. D S Rao Practicing Company Secretary. |
Fri, 09 Jun 2023 |
|
|
|
|
|